Intervacc ABFRA:2E9 +0.31%63 Days Inventory is 399.75 as of Mar. 2026, which is 68% above its 10-year median of 237.53. GuruFocus rates FRA:2E9 with a GF Score™ of 63/100 and a GF Value™ of €0.08. The stock has 5 warning signs investors should review. Among 637 Biotechnology companies, Intervacc AB ranks worse than 52.59% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Intervacc AB's Average Total Inventories for the
three
months ended in Mar. 2026 was €0.94 Mil. Intervacc AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €0.21 Mil.
Hence, Intervacc AB's Days Inventory for the
three
months ended in Mar. 2026 was 399.75.
The historical rank and industry rank for Intervacc AB's Days Inventory or its related term are showing as below:
FRA:2E9'
s Days Inventory Range Over the Past 10 Years
Min: 125.83 Med: 237.53 Max: 3572.74
Current: 192.27
During the past 12 years, Intervacc AB's highest Days Inventory was 3572.74. The lowest was 125.83. And the median was 237.53.
FRA:2E9's Days Inventory is ranked worse than 52.59% of 637
companies
in the Biotechnology industry
Industry Median: 183.23
vs FRA:2E9: 192.27
Intervacc AB's Days Inventory
declined
from Mar. 2025 (439.60) to Mar. 2026 (399.75).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Intervacc AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Intervacc AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 3.00.
Intervacc AB (FRA:2E9) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Intervacc AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Intervacc AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Intervacc AB Days Inventory Related Terms
Intervacc AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Intervacc AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2E9 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Intervacc AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intervacc AB Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Intervacc AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Intervacc AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intervacc AB (FRA:2E9) has a Days Inventory of 399.75 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Intervacc AB and its competitors. This is 68% above median its historical median of 237.53. Over the past decade, Intervacc AB's Days Inventory has ranged from 125.83 to 3,572.74. According to the industry distribution chart, Intervacc AB ranks #335 out of 637 companies in the Biotechnology industry, placing it in the top 52.6%.
Is Intervacc AB's Days Inventory too high?
Intervacc AB's current Days Inventory of 399.75 is 68% above median its 10-year median of 237.53. Over the past 10 years, this metric has ranged from a low of 125.83 to a high of 3,572.74. The Biotechnology industry median Days Inventory is 183.23. Intervacc AB's value of 399.75 is 118.2% above this industry median. Based on the distribution chart, Intervacc AB ranks #335 out of 637 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Intervacc AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Intervacc AB's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Intervacc AB ranks #335 out of 637 companies for Days Inventory. This places Intervacc AB in the lower half of its industry. The industry median Days Inventory is 183.23. Intervacc AB's value of 399.75 is 118.2% above this benchmark. Historically, Intervacc AB's own Days Inventory has ranged from 125.83 to 3,572.74 over the past decade. While the company's 10-year median is 237.53 vs. the industry median of 183.23, Intervacc AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intervacc AB's current Days Inventory of 399.75 is 118.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Intervacc AB and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intervacc AB's current Days Inventory is 399.75, which is 68% above median its own 10-year median of 237.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intervacc AB stock overvalued right now?
Intervacc AB (FRA:2E9) has a current Days Inventory of 399.75. The stock's GF Value™ is €0.08, compared to a current price of €0.10 — trading 22.3% above its estimated fair value. The current Days Inventory is 399.75, which is 68% above median its 10-year median of 237.53 and 118.2% above the Biotechnology industry median of 183.23. Intervacc AB's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Intervacc AB (FRA:2E9), the current Days Inventory is 399.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intervacc AB (FRA:2E9) Overvalued in 2026?
Based on GuruFocus' analysis, Intervacc AB stock appears to be overvalued.
The current stock price of €0.10 is trading 22.3% above its estimated GF Value™ of €0.08.
Key valuation signals for FRA:2E9:
Days Inventory: 399.75 (68% above median its 10-year median of 237.53)
GF Value™: €0.08 vs. price of €0.10 (22.3% above fair value)
Industry Position: 118.2% above the Biotechnology median (#335 of 637)
No single metric tells the full story. See the FRA:2E9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
63GF Score
Get the complete analysis for FRA:2E9
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2E9 has been successfully added to your 
